drugset / Trial / NCT06054464
A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants
Non-randomizedSequentialOpen-labelOther
Summary
This study will assess the effect of a Proton Pump Inhibitor (PPI) (rabeprazole) on the pharmacokinetics (PK) of PC14586 and the effect of an H2-receptor antagonist (famotidine) on the PK of PC14586
Timeline
- Start
- 2023-09-19
- Primary completion
- 2023-11-03
- Completion
- 2024-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | — | Oral |
| Subject | Rabeprazole | Small molecule | — | Oral |
| Subject | rezatapopt | Small molecule | — | Oral |
Indications
No indication recorded.